Public preview. Funding rounds, founders, and growth signals require a free account.

NovAb, Inc.

Develops VLR-based antibodies from lampreys for treating plasma cell malignancies.[1]

SeedBiotechTucker, GA1-10 employees

Total raised

$1.5M

Last round

Convertible Note

$50K · Jan 2026

Stage

Seed

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment NovAb, Inc. files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.